Related Experiment Video
Updated: Nov 27, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Elevated levels of D-dimer in patients with COVID-19: prognosis value
Sara Oualim1, Salma Abdeladim1, Amal El Ouarradi1
1Department of cardiology, Cheick Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
Insights
Elevated D-dimer levels in COVID-19 patients can predict poor outcomes. A D-dimer level above 1360 ng/ml on day 5 indicates a higher risk of in-hospital mortality.
Area of Science:
- Medical Research
- Infectious Diseases
- Hematology
Background:
- Coronavirus disease (COVID-19) is a global pandemic with significant respiratory, cardiovascular, and neurological impacts.
- Rapid human-to-human transmission necessitates effective prognostic markers for COVID-19 progression.
- Elevated D-dimer levels are investigated as potential indicators of severe COVID-19 outcomes.
Purpose of the Study:
- To determine if elevated D-dimer levels predict poor progression of COVID-19.
- To assess the prognostic value of D-dimer levels for reducing COVID-19 mortality.
- To identify optimal D-dimer cutoff values for predicting in-hospital mortality.
Main Methods:
- Retrieved data from 89 COVID-19 patients treated between March 21 and April 24, 2020.
- Utilized Receiver Operating Characteristic (ROC) curves to establish D-dimer cutoff values on admission and day 5.
- Compared in-hospital mortality rates between patient groups stratified by D-dimer levels.
Main Results:
- An admission D-dimer cutoff of 668 ng/ml predicted mortality with 90% sensitivity and 63.3% specificity (AUC 0.775).
- A day 5 D-dimer cutoff of 1360 ng/ml predicted mortality with 100% sensitivity and 88.6% specificity (AUC 0.946).
- Patients with day 5 D-dimer > 1360 ng/ml (19 patients) exhibited worse outcomes and significantly higher mortality (10/19) compared to those with levels < 1360 ng/ml (0/69, P = 0.0002).
Conclusions:
- D-dimer levels exceeding 1360 ng/ml on day 5 are a strong predictor of poor prognosis in COVID-19 patients.
- This finding aids clinicians in early identification of high-risk individuals.
- Early identification facilitates timely interventions to potentially reduce COVID-19 mortality.
Introduction:
coronavirus disease is now a global pandemic due to rapid human-to-human transmission. It can cause mild to fatal respiratory, cardiovascular, and neurological diseases. We aimed to find out whether elevated D-dimer levels are a predictor of the bad progression of COVID-19 to help reducing the mortality.
Methods:
the data of COVID-19 patients from March 21, 2020 to April 24, 2020 were retrieved from the Cheick Khalifa Hospital database. We used the receiver operating characteristic (ROC) curve to get the optimum cutoff value of D-dimer levels on admission and after 5 days. We used these cutoffs to divide patients into two groups and compare the in-hospital mortality between them to assess the prognosis value of D-dimer levels.
Results:
the data of COVID-19 patients from March 21, 2020 to April 24, 2020 were retrieved from the Cheick Khalifa Hospital database. We used the receiver operating characteristic (ROC) curve to get the optimum cutoff value of D-dimer levels on admission and after 5 days. We used these cutoffs to divide patients into two groups and compare the in-hospital mortality between them to assess the prognosis value of D-dimer levels. 89 patients were included in this study, of whom 79 were discharged and 10 died in hospital. The optimum cutoff value to predict mortality in patient using D-dimer levels on admission was 668 ng/ml (sensitivity 90%, specificity 63.3%, Areas under the ROC curve 0,775). As for D-dimer levels on day 5, it was 1360 ng/ml (sensitivity 100%, specificity 88,6%, Areas under the ROC curve 0.946). The group with D-dimer levels on day 5 > 1360 ng/ml (19 patients) had a worst evolution and a higher incidence of mortality compared to the group with D-dimer < 1360 ng/ml (69 patients) (10/19 vs 0/69, P = 0,0002).
Conclusion:
D-dimer greater than 1360 ng/ml on day 5 could help clinicians identify patients with poor prognosis at an early stage of COVID-19.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism III: Nursing Management

